5KYJ image
Deposition Date 2016-07-21
Release Date 2016-09-21
Last Version Date 2023-10-04
Entry Detail
PDB ID:
5KYJ
Title:
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.25
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Oxysterols receptor LXR-beta
Gene (Uniprot):NR1H2
Mutagens:G213H, E214M, Q259A, R261G, D262S, R264S
Chain IDs:A, C (auth: E)
Chain Length:287
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Retinoic acid receptor RXR-beta
Gene (Uniprot):RXRB
Mutagens:G293M
Chain IDs:B, D (auth: F)
Chain Length:256
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core.
Bioorg.Med.Chem.Lett. 26 5044 5050 (2016)
PMID: 27599745 DOI: 10.1016/j.bmcl.2016.08.089

Abstact

Liver X receptor (LXR) agonists have been reported to lower brain amyloid beta (Aβ) and thus to have potential for the treatment of Alzheimer's disease. Structure and property based design led to the discovery of a series of orally bioavailable, brain penetrant LXR agonists. Oral administration of compound 18 to rats resulted in significant upregulation of the expression of the LXR target gene ABCA1 in brain tissue, but no significant effect on Aβ levels was detected.

Legend

Protein

Chemical

Disease

Primary Citation of related structures